Home
About
Overview
Sharing Data
ORCID
Help
History (6)
High-dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignancies.
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study.
Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.
Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
Overcoming toxicity and side-effects of lipid-lowering therapies.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overcoming toxicity and side-effects of lipid-lowering therapies.
Overcoming toxicity and side-effects of lipid-lowering therapies. Best Pract Res Clin Endocrinol Metab. 2014 Jun; 28(3):439-52.
View in:
PubMed
subject areas
Chemical and Drug Induced Liver Injury
Dose-Response Relationship, Drug
Drug-Related Side Effects and Adverse Reactions
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Kidney Diseases
Muscular Diseases
Nervous System Diseases
Risk Factors
authors with profiles
Michael Davidson